LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Canc Netw. 2021;19(3):254–266.
   PubMed Web of Science ®Google Scholar
• Hurley K, Ding J, Villacorta-Martin C, et al. Reconstructed single-cell fate trajectories define lineage plasticity windows during differentiation of human PSC-derived distal lung progenitors. Cell Stem Cell. 2020;26(4):593–608.e8.
   PubMed Web of Science ®Google Scholar
• Tragante V, Moore JH, Asselbergs FW. The ENCODE project and perspectives on pathways. Genet Epidemiol. 2014;38(4):275–280.
   PubMed Web of Science ®Google Scholar
• Lodde V, Murgia G, Simula ER, et al. Long noncoding RNAs and circular RNAs in autoimmune diseases. Biomolecules. 2020;10(7):1044.
   PubMed Web of Science ®Google Scholar
• Sparber P, Filatova A, Khantemirova M, et al. The role of long non-coding RNAs in the pathogenesis of hereditary diseases. BMC Med Genomics. 2019;12(Suppl 2):42.
   PubMedGoogle Scholar
• Melixetian M, Pelicci PG, Lanfrancone L. Regulation of LncRNAs in melanoma and their functional roles in the metastatic process. Cells. 2022;11(3):577.
   PubMed Web of Science ®Google Scholar
• Sun Z, Xue C, Li J, et al. LINC00244 suppresses cell growth and metastasis in hepatocellular carcinoma by downregulating programmed cell death ligand 1. Bioengineered. 2022;13(3):7635–7647.
   PubMed Web of Science ®Google Scholar
• Guan M, Huang Y, Lin X. Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt/beta-catenin signaling pathway. Bioengineered. 2022;13(4):10857–10865.
   PubMed Web of Science ®Google Scholar
• Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84.
   PubMed Web of Science ®Google Scholar
• Wilson MM, Weinberg RA, Lees JA, et al. Emerging mechanisms by which EMT programs control stemness. Trends Cancer. 2020;6(9):775–780.
   PubMed Web of Science ®Google Scholar
• Huang H, Yang C, Zhang Q, et al. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Bioengineered. 2022;13(3):4964–4977.
   PubMed Web of Science ®Google Scholar
• Han Q, Li J, Xiong J, et al. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. J Exp Clin Cancer Res. 2020;39(1):151.
   PubMed Web of Science ®Google Scholar
• Li X, Zhong W, Xu Y, et al. Silencing of lncRNA LINC00514 inhibits the malignant behaviors of papillary thyroid cancer through miR-204-3p/CDC23 axis. Biochem Biophys Res Commun. 2019;508(4):1145–1148.
   PubMed Web of Science ®Google Scholar
• Liu X, Shen X, Zhang J. Long non-coding RNA LINC00514 promotes the proliferation and invasion through the miR-708-5p/HOXB3 axis in cervical squamous cell carcinoma. Environ Toxicol. 2022;37(1):161–170.
   PubMed Web of Science ®Google Scholar
• Tao S, Chen Q, Lin C, et al. Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway. J Exp Clin Cancer Res. 2020;39(1):191.
   PubMed Web of Science ®Google Scholar
• Luo X, Wang H. LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple-negative breast cancer by sponging miR-6504-5p and miR-3139. Cancer Cell Int. 2021;21(1):180.
   PubMed Web of Science ®Google Scholar
• Mi LD, Sun CX, He SW, et al. SP1-induced upregulation of lncRNA LINC00514 promotes tumor proliferation and metastasis in osteosarcoma by regulating miR-708. Cancer Manag Res. 2020;12:3311–3322.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu H, Zhang Q, et al. LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression. Int J Oncol. 2021;59(5). DOI:10.3892/ijo.2021.5266.
   Web of Science ®Google Scholar
• Li Z, Liu L, Jiang S, et al. LncExpDB: an expression database of human long non-coding RNAs. Nucleic Acids Res. 2021;49(D1):D962–d8.
   PubMed Web of Science ®Google Scholar
• Guo Z, Liang E, Li W, et al. Essential meiotic structure-specific endonuclease1 () promotes malignant features in gastric cancer cells via the Akt/GSK3B/CCND1 pathway. Bioengineered. 2021;12(2):9869–9884.
   PubMed Web of Science ®Google Scholar
• Yang B, Diao H, Wang P, et al. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1. Bioengineered. 2021;12(1):9094–9102.
   PubMed Web of Science ®Google Scholar
• Chai J, Qin L, Zhang G, et al. Long non-coding MELTF antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299. Bioengineered. 2022;13(4):10594–10604.
   PubMed Web of Science ®Google Scholar
• Qian F, Hu Q, Tian Y, et al. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis. Int J Biol Sci. 2019;15(2):369–385.
   PubMed Web of Science ®Google Scholar
• Györffy B, Lanczky A, Eklund AC, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725–731.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen Q, Cheng Z, et al. Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death Dis. 2020;11(10):858.
   PubMed Web of Science ®Google Scholar
• Liu J, Yao L, Zhang M, et al. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11(18):7830–7846.
   PubMedGoogle Scholar
• Jiang WG, Sanders AJ, Katoh M, et al. Tissue invasion and metastasis: molecular, biological and clinical perspectives. Semin Cancer Biol. 2015;35 Suppl:S244–s75.
   PubMed Web of Science ®Google Scholar
• Pai SG, Carneiro BA, Mota JM, et al. Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol. 2017;10(1):101.
   PubMedGoogle Scholar
• Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60.
   PubMed Web of Science ®Google Scholar
• Tang Q, Chen J, Di Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 2020;39(1):232.
   PubMed Web of Science ®Google Scholar
• Song J, Xie C, Jiang L, et al. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma. Theranostics. 2018;8(13):3571–3583.
   PubMed Web of Science ®Google Scholar
• Sebio A, Kahn M, Lenz HJ. The potential of targeting Wnt/β-catenin in colon cancer. Expert Opin Ther Targets. 2014;18(6):611–615.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Li X, Hydbring P, et al. The requirement for cyclin D function in tumor maintenance. Cancer Cell. 2012;22(4):438–451.
   PubMed Web of Science ®Google Scholar
• Jung H-Y, Yang J. Unraveling the TWIST between EMT and cancer stemness. Cell Stem Cell. 2015;16(1):1–2.
   PubMed Web of Science ®Google Scholar
• Tulchinsky E, Demidov O, Kriajevska M, et al. EMT: a mechanism for escape from EGFR-targeted therapy in lung cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(1):29–39.
   PubMed Web of Science ®Google Scholar
• Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15(1):18.
   PubMedGoogle Scholar
• Yuan L, Li J, Yang Y, et al. LINC00514 promotes gastric cancer cell growth and EMT progression via miR-204-3p/KRAS. Aging (Albany NY). 2021;13(8):12007–12015.
   PubMedGoogle Scholar
• Pan J, Fang S, Tian H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer. 2020;19(1):9.
   PubMed Web of Science ®Google Scholar
• Yang G-J, Wang W, Mok SWF, et al. Selective inhibition of lysine-specific demethylase 5A (KDM5A) using a rhodium(III) complex for triple-negative breast cancer therapy. Angewandte Chemie. 2018;57(40):13091–13095.
   Google Scholar
• Cheng -S-S, Qu Y-Q, Wu J, et al. Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer. Acta Pharm Sin B. 2022;12(3):1390–1405.
   PubMed Web of Science ®Google Scholar